ClinicalTrials.gg
CompletedNCT01803113Updated Mar 13, 2013

Sofia hCG FIA Field Study

An observational study in Pregnancy, Early Detection, sponsored by Quidel Corporation. Completed at 5 sites in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2013-03-13.

Sponsored by Quidel Corporation · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
975
Sex
Female
01

Study summary

The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.

Read the detailed description

Subjects presenting for pregnancy testing will provide urine specimens that will be tested with the Sofia hCG FIA test and the comparator pregnancy test that will detect levels of hCG of 20mIU as positive for pregnancy.

02

Conditions studied

  • Pregnancy, Early Detection

Keywords

  • Pregnancy
  • hCG
03

In context

Lead sponsor

Quidel Corporation is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Any female of childbearing potential being screened for pregnancy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female subjects of childbearing age, who are being screened for pregnancy and who have signed the

Exclusion criteria

Exclusion Criteria:

  • Subject is .
  • Subject within the past six weeks has experienced any of the following: delivered a newborn; had an abortion or a natural termination (miscarriage); or, received hCG supplements.
  • Subject has had a hysterectomy.
  • Unable to understand and consent to participation.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Time perspective
Prospective
Enrollment
975 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Interventions

  • DeviceSofia hCG FIA

    Qualitative detection via immunofluorescence technology of increased level of hCG present in urine.

06

What researchers measure

Primary outcomes

  1. Determination of presence of hCG in urine

    Clinical performance will be based on comparison of Sofia hCG FIA test results to those obtained from an FDA-cleared hCG test.

    Time frame: 1 day

07

Study locations

5 sites
  • Jose Castaneda, MD
    Boynton Beach, Florida 33435-7959, United States
  • NECCR of Massachusetts, LLC
    Fall River, Massachusetts 02720, United States
  • New England Center for Clinical Research Fall River,LLC (NECCR)
    Fall River, Massachusetts 02720, United States
  • Partners In Obstetrics and Gynecology, Inc.
    Pawtucket, Rhode Island 02860, United States
  • Planned Parenthood Gulf Coast
    Houston, Texas 77023, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01803113
Lead sponsor
Quidel Corporation
Responsible party
Sponsor
First posted
Mar 4, 2013
Start date
Jan 2013
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Mar 13, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion